Nintedanib, gefitinib, erlotinib, afatinib, osimertinib: clinical trials recruiting now
Fewer than 3 recruiting trials found.
1
Recruiting trials
4
Conditions studied
0
US states with sites
1
Countries
Phase breakdown
Phase 1 1
Phase 2 1
Conditions being studied
| Condition | Trials |
|---|---|
| EGFR Gene Mutation | 1 |
| EGFR-TKI Resistant Mutation | 1 |
| Lung cancer | 1 |
| Non-small Cell Lung Cancer | 1 |
Recruiting trials involving Nintedanib, gefitinib, erlotinib, afatinib, osimertinib
Common questions
How many recruiting trials involve Nintedanib, gefitinib, erlotinib, afatinib, osimertinib?
1 recruiting trial across 4 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.